Principal Financial Group Inc Mersana Therapeutics, Inc. Transaction History

Principal Financial Group Inc

$160 Billion
Q2 2024

A detailed history of Principal Financial Group Inc transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 18,278 shares of MRSN stock, worth $34,545. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,278

Previous 31,775 42.48%

Holding current value

$34,545

Previous $142,000 74.65%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$2.0 - $4.45 $26,994 - $60,061	-13,497 Reduced 42.48%	18,278 $36,000
Q1 2024 Apr 29, 2024	SELL	$2.16 - $5.94 $3,676 - $10,109	-1,702 Reduced 5.08%	31,775 $142,000
Q4 2023 Feb 07, 2024	BUY	$1.11 - $2.34 $1,915 - $4,038	1,726 Added 5.44%	33,477 $77,000
Q3 2023 Nov 02, 2023	BUY	$1.06 - $3.91 $1,496 - $5,520	1,412 Added 4.65%	31,751 $40,000
Q2 2023 Aug 07, 2023	BUY	$3.08 - $9.55 $15,021 - $46,575	4,877 Added 19.15%	30,339 $99,000
Q1 2023 May 09, 2023	BUY	$4.0 - $7.02 $14,380 - $25,236	3,595 Added 16.44%	25,462 $104,000
Q4 2022 Feb 09, 2023	BUY	$5.65 - $7.86 $16,650 - $23,163	2,947 Added 15.58%	21,867 $128,000
Q3 2022 Nov 09, 2022	BUY	$4.63 - $8.0 $23,066 - $39,856	4,982 Added 35.74%	18,920 $128,000
Q2 2022 Aug 10, 2022	BUY	$2.84 - $5.0 $7,863 - $13,845	2,769 Added 24.79%	13,938 $64,000
Q1 2022 May 09, 2022	BUY	$3.74 - $6.63 $2,460 - $4,362	658 Added 6.26%	11,169 $45,000
Q4 2021 Feb 09, 2022	SELL	$5.48 - $9.86 $84,950 - $152,849	-15,502 Reduced 59.59%	10,511 $65,000
Q3 2021 Nov 09, 2021	SELL	$8.56 - $14.47 $231 - $390	-27 Reduced 0.1%	26,013 $245,000
Q2 2021 Aug 10, 2021	SELL	$13.28 - $18.07 $731,940 - $995,946	-55,116 Reduced 67.91%	26,040 $353,000
Q1 2021 May 10, 2021	BUY	$15.31 - $26.52 $51,640 - $89,451	3,373 Added 4.34%	81,156 $1.31 Million
Q4 2020 Feb 08, 2021	BUY	$16.84 - $27.59 $1.31 Million - $2.15 Million	77,783 New	77,783 $2.07 Million

Others Institutions Holding MRSN

# of Institutions

124

Shares Held

114M

Call Options Held

73.5K

Put Options Held

46.4K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $184M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Mersana Therapeutics, Inc. Transaction History